BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24422606)

  • 1. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
    Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
    Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants at 8q24 are associated with prostate cancer risk in Serbian population.
    Branković AS; Brajušković GN; Mirčetić JD; Nikolić ZZ; Kalaba PB; Vukotić VD; Tomović SM; Cerović SJ; Radojičić ZA; Savić-Pavićević DL; Romac SP
    Pathol Oncol Res; 2013 Jul; 19(3):559-69. PubMed ID: 23532531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.
    Branković A; Brajušković G; Nikolić Z; Vukotić V; Cerović S; Savić-Pavićević D; Romac S
    Int J Exp Pathol; 2013 Dec; 94(6):355-61. PubMed ID: 23998439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a single-nucleotide polymorphism from chromosome 17q12 with the aggressiveness of prostate cancer in a Hispanic population.
    Rojas PA; Torres-Estay V; Cerda-Infante J; Montecinos VP; Domínguez J; Arenas J; Godoy AS; San Francisco IF
    J Cancer Res Clin Oncol; 2014 May; 140(5):783-8. PubMed ID: 24627192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
    Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
    Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.
    Levin AM; Machiela MJ; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
    Cancer Res; 2008 Aug; 68(16):6492-5. PubMed ID: 18701471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of association between genetic variants in microRNA genes hsa-miR-499, hsa-miR-196a2 and hsa-miR-27a and prostate cancer risk in Serbian population.
    Nikolić Z; Savić Pavićević D; Vučić N; Cidilko S; Filipović N; Cerović S; Vukotić V; Romac S; Brajušković G
    Exp Mol Pathol; 2015 Aug; 99(1):145-50. PubMed ID: 26112096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
    Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
    HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
    Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
    DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men.
    Silva-Ramirez B; Macías-González EJ; Frausto-Valdes OS; Calao-Pérez MB; Ibarra-Pérez DI; Torres-García JE; Aragón-Tovar AR; Peñuelas-Urquides K; González-Escalante LA; Bermúdez de León M
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):507-512. PubMed ID: 34599275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
    Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
    Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
    Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
    Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
    Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
    Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
    Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
    Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
    Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
    Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
    Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.
    Chen Y; Li T; Yu X; Xu J; Li J; Luo D; Mo Z; Hu Y
    Gene; 2014 Jan; 534(2):286-97. PubMed ID: 24177231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in RNA-induced silencing complex genes and prostate cancer.
    Nikolić Z; Savić Pavićević D; Vučić N; Cerović S; Vukotić V; Brajušković G
    World J Urol; 2017 Apr; 35(4):613-624. PubMed ID: 27498138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.